Name: | Description: | Size: | Format: | |
---|---|---|---|---|
576.45 KB | Adobe PDF |
Advisor(s)
Abstract(s)
In 2020, around 60,000 people were diagnosed with cancer in Portugal, and many of them
suffered some level of Fear of Progression (FoP) of the disease. Although this FoP is realistic, and
is part of the normal and appropriate response to this type of disease, there is no instrument to
assess and understand whether it is exaggerated in the face of the situation. The present study
aimed to translate and validate the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) for the
Portuguese population. The sample consisted of 220 volunteers, aged 18 years or over and diagnosed
with cancer for at least six months. Participants completed the FoP-Q-SF, the Hospital Anxiety and
Depression Scale (HADS), the European Organization for Research and Treatment of Cancer Quality
of Life Questionnaire Core-30 (EORTC QLQ-C30) and the Post-Traumatic Stress Disorder ChecklistCivilian Version (PCL-C). The FoP-Q-SF demonstrated high internal reliability (α = 0.86) and the
confirmatory factor analysis supported the one-dimensional structure of the FoP-Q-SF. Convergent
validity was supported with significant positive correlations with psychological distress, especially
anxiety (0.68). The FoP-Q-SF has been found to be a valid instrument to measure FoP in Portuguese
cancer survivors.
Description
Keywords
Fear of progression questionnaire Validation Cancer survivors